JPWO2021189059A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021189059A5 JPWO2021189059A5 JP2022556568A JP2022556568A JPWO2021189059A5 JP WO2021189059 A5 JPWO2021189059 A5 JP WO2021189059A5 JP 2022556568 A JP2022556568 A JP 2022556568A JP 2022556568 A JP2022556568 A JP 2022556568A JP WO2021189059 A5 JPWO2021189059 A5 JP WO2021189059A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence encodes
- expression sequence
- cancer
- virus
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091028075 Circular RNA Proteins 0.000 claims description 121
- 108091008874 T cell receptors Proteins 0.000 claims description 49
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 49
- 108091023040 Transcription factor Proteins 0.000 claims description 33
- 102000040945 Transcription factor Human genes 0.000 claims description 33
- 239000002105 nanoparticle Substances 0.000 claims description 33
- 102000004127 Cytokines Human genes 0.000 claims description 30
- 108090000695 Cytokines Proteins 0.000 claims description 30
- 241000700605 Viruses Species 0.000 claims description 26
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 25
- 125000006850 spacer group Chemical group 0.000 claims description 21
- 102000019034 Chemokines Human genes 0.000 claims description 20
- 108010012236 Chemokines Proteins 0.000 claims description 20
- 206010028980 Neoplasm Diseases 0.000 claims description 20
- 239000012634 fragment Substances 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 19
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 18
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 claims description 18
- 108091027874 Group I catalytic intron Proteins 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 102000040430 polynucleotide Human genes 0.000 claims description 15
- 108091033319 polynucleotide Proteins 0.000 claims description 15
- 239000002157 polynucleotide Substances 0.000 claims description 15
- 230000008685 targeting Effects 0.000 claims description 14
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 201000011510 cancer Diseases 0.000 claims description 12
- 150000002632 lipids Chemical class 0.000 claims description 11
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 10
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 claims description 10
- 229960004413 flucytosine Drugs 0.000 claims description 10
- 229960002949 fluorouracil Drugs 0.000 claims description 10
- 230000001225 therapeutic effect Effects 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 9
- 238000003776 cleavage reaction Methods 0.000 claims description 9
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 9
- -1 IL -15 Proteins 0.000 claims description 8
- 108010006519 Molecular Chaperones Proteins 0.000 claims description 8
- 102000005431 Molecular Chaperones Human genes 0.000 claims description 8
- 239000003112 inhibitor Substances 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 102100027581 Forkhead box protein P3 Human genes 0.000 claims description 7
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 claims description 7
- 101100452383 Homo sapiens IKZF2 gene Proteins 0.000 claims description 7
- 101150063267 STAT5B gene Proteins 0.000 claims description 7
- 102100024474 Signal transducer and activator of transcription 5B Human genes 0.000 claims description 7
- 102100037796 Zinc finger protein Helios Human genes 0.000 claims description 7
- 210000005260 human cell Anatomy 0.000 claims description 7
- 230000007017 scission Effects 0.000 claims description 7
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 6
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 claims description 6
- 241000531123 GB virus C Species 0.000 claims description 6
- 241000282412 Homo Species 0.000 claims description 6
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 claims description 6
- 101100260032 Mus musculus Tbx21 gene Proteins 0.000 claims description 6
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 6
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 claims description 6
- 239000000427 antigen Substances 0.000 claims description 6
- 108091007433 antigens Proteins 0.000 claims description 6
- 102000036639 antigens Human genes 0.000 claims description 6
- ASKSDLRLUXEOOR-SUFRFZPQSA-N gbv-c Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=3C4=CC=CC=C4NC=3)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC(C)C)=CNC2=C1 ASKSDLRLUXEOOR-SUFRFZPQSA-N 0.000 claims description 6
- 238000001727 in vivo Methods 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 230000004083 survival effect Effects 0.000 claims description 6
- 108010065805 Interleukin-12 Proteins 0.000 claims description 5
- 108010002350 Interleukin-2 Proteins 0.000 claims description 5
- 108010002586 Interleukin-7 Proteins 0.000 claims description 5
- 230000001363 autoimmune Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 4
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 claims description 4
- 241000256844 Apis mellifera Species 0.000 claims description 4
- 108091023037 Aptamer Proteins 0.000 claims description 4
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 4
- 206010005003 Bladder cancer Diseases 0.000 claims description 4
- 108020004414 DNA Proteins 0.000 claims description 4
- 241000710188 Encephalomyocarditis virus Species 0.000 claims description 4
- 101710091919 Eukaryotic translation initiation factor 4G Proteins 0.000 claims description 4
- 241000709721 Hepatovirus A Species 0.000 claims description 4
- 241001129848 Homalodisca coagulata virus-1 Species 0.000 claims description 4
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims description 4
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 claims description 4
- 108090000174 Interleukin-10 Proteins 0.000 claims description 4
- 108090000172 Interleukin-15 Proteins 0.000 claims description 4
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 claims description 4
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims description 4
- 206010038389 Renal cancer Diseases 0.000 claims description 4
- 241000125167 Rhopalosiphum padi Species 0.000 claims description 4
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 4
- 241001223089 Tremovirus A Species 0.000 claims description 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 4
- 239000005557 antagonist Substances 0.000 claims description 4
- 125000002091 cationic group Chemical group 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 4
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 claims description 4
- 208000014829 head and neck neoplasm Diseases 0.000 claims description 4
- 208000006454 hepatitis Diseases 0.000 claims description 4
- 231100000283 hepatitis Toxicity 0.000 claims description 4
- 102000050291 human RUNX1 Human genes 0.000 claims description 4
- 201000010982 kidney cancer Diseases 0.000 claims description 4
- 208000023275 Autoimmune disease Diseases 0.000 claims description 3
- 108700011259 MicroRNAs Proteins 0.000 claims description 3
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 3
- 239000011258 core-shell material Substances 0.000 claims description 3
- 230000004907 flux Effects 0.000 claims description 3
- 210000002865 immune cell Anatomy 0.000 claims description 3
- 239000002679 microRNA Substances 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 230000010837 receptor-mediated endocytosis Effects 0.000 claims description 3
- 108091008146 restriction endonucleases Proteins 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- 102100024341 10 kDa heat shock protein, mitochondrial Human genes 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 101150059573 AGTR1 gene Proteins 0.000 claims description 2
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 2
- 241001036151 Aichi virus 1 Species 0.000 claims description 2
- 208000007860 Anus Neoplasms Diseases 0.000 claims description 2
- 241001261139 Aphid lethal paralysis virus Species 0.000 claims description 2
- 102100027308 Apoptosis regulator BAX Human genes 0.000 claims description 2
- 241001113710 Bakunsa virus Species 0.000 claims description 2
- 208000023328 Basedow disease Diseases 0.000 claims description 2
- 206010005949 Bone cancer Diseases 0.000 claims description 2
- 208000018084 Bone neoplasm Diseases 0.000 claims description 2
- 241001118702 Border disease virus Species 0.000 claims description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 claims description 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 2
- 240000000385 Brassica napus var. napus Species 0.000 claims description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 2
- 206010006187 Breast cancer Diseases 0.000 claims description 2
- 208000026310 Breast neoplasm Diseases 0.000 claims description 2
- 208000011691 Burkitt lymphomas Diseases 0.000 claims description 2
- 108050005711 C Chemokine Proteins 0.000 claims description 2
- 102000017483 C chemokine Human genes 0.000 claims description 2
- 102100023702 C-C motif chemokine 13 Human genes 0.000 claims description 2
- 102100023705 C-C motif chemokine 14 Human genes 0.000 claims description 2
- 102100023703 C-C motif chemokine 15 Human genes 0.000 claims description 2
- 102100023701 C-C motif chemokine 18 Human genes 0.000 claims description 2
- 102100036842 C-C motif chemokine 19 Human genes 0.000 claims description 2
- 102100036848 C-C motif chemokine 20 Human genes 0.000 claims description 2
- 102100036846 C-C motif chemokine 21 Human genes 0.000 claims description 2
- 102100036850 C-C motif chemokine 23 Human genes 0.000 claims description 2
- 102100036849 C-C motif chemokine 24 Human genes 0.000 claims description 2
- 102100021933 C-C motif chemokine 25 Human genes 0.000 claims description 2
- 102100021935 C-C motif chemokine 26 Human genes 0.000 claims description 2
- 102100021936 C-C motif chemokine 27 Human genes 0.000 claims description 2
- 102100021942 C-C motif chemokine 28 Human genes 0.000 claims description 2
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims description 2
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims description 2
- 102100034871 C-C motif chemokine 8 Human genes 0.000 claims description 2
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims description 2
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 claims description 2
- 102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims description 2
- 102100025250 C-X-C motif chemokine 14 Human genes 0.000 claims description 2
- 102100039396 C-X-C motif chemokine 16 Human genes 0.000 claims description 2
- 102100039435 C-X-C motif chemokine 17 Human genes 0.000 claims description 2
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 claims description 2
- 102100036189 C-X-C motif chemokine 3 Human genes 0.000 claims description 2
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims description 2
- 102000001902 CC Chemokines Human genes 0.000 claims description 2
- 108010040471 CC Chemokines Proteins 0.000 claims description 2
- 101150049756 CCL6 gene Proteins 0.000 claims description 2
- 101150011672 CCL9 gene Proteins 0.000 claims description 2
- 108050006947 CXC Chemokine Proteins 0.000 claims description 2
- 102000019388 CXC chemokine Human genes 0.000 claims description 2
- 241000282836 Camelus dromedarius Species 0.000 claims description 2
- 101100507655 Canis lupus familiaris HSPA1 gene Proteins 0.000 claims description 2
- 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 claims description 2
- 101150075117 Ccl12 gene Proteins 0.000 claims description 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 2
- 108010059013 Chaperonin 10 Proteins 0.000 claims description 2
- 108010058432 Chaperonin 60 Proteins 0.000 claims description 2
- 241000710777 Classical swine fever virus Species 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 241000146367 Coxsackievirus A10 Species 0.000 claims description 2
- 241000709677 Coxsackievirus B1 Species 0.000 claims description 2
- 241000709675 Coxsackievirus B3 Species 0.000 claims description 2
- 241000709711 Coxsackievirus B5 Species 0.000 claims description 2
- 241000710127 Cricket paralysis virus Species 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 102100035298 Cytokine SCM-1 beta Human genes 0.000 claims description 2
- 102000000311 Cytosine Deaminase Human genes 0.000 claims description 2
- 108010080611 Cytosine Deaminase Proteins 0.000 claims description 2
- 108700006830 Drosophila Antp Proteins 0.000 claims description 2
- 241000907524 Drosophila C virus Species 0.000 claims description 2
- 108700007251 Drosophila H Proteins 0.000 claims description 2
- 108700024069 Drosophila Ubx Proteins 0.000 claims description 2
- 108700007861 Drosophila rpr Proteins 0.000 claims description 2
- 241000217413 Echovirus E14 Species 0.000 claims description 2
- 241000201383 Echovirus E7 Species 0.000 claims description 2
- 241000972718 Ectropis obliqua picorna-like virus Species 0.000 claims description 2
- 102100031780 Endonuclease Human genes 0.000 claims description 2
- 108010042407 Endonucleases Proteins 0.000 claims description 2
- 241000709661 Enterovirus Species 0.000 claims description 2
- 241001529459 Enterovirus A71 Species 0.000 claims description 2
- 241000991587 Enterovirus C Species 0.000 claims description 2
- 241000991586 Enterovirus D Species 0.000 claims description 2
- 241000033074 Enterovirus J Species 0.000 claims description 2
- 102100023688 Eotaxin Human genes 0.000 claims description 2
- 241000283073 Equus caballus Species 0.000 claims description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 2
- 201000008808 Fibrosarcoma Diseases 0.000 claims description 2
- 241000710198 Foot-and-mouth disease virus Species 0.000 claims description 2
- 102100020997 Fractalkine Human genes 0.000 claims description 2
- 208000022072 Gallbladder Neoplasms Diseases 0.000 claims description 2
- 208000007882 Gastritis Diseases 0.000 claims description 2
- 208000015023 Graves' disease Diseases 0.000 claims description 2
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims description 2
- 208000001204 Hashimoto Disease Diseases 0.000 claims description 2
- 208000030836 Hashimoto thyroiditis Diseases 0.000 claims description 2
- 102100034051 Heat shock protein HSP 90-alpha Human genes 0.000 claims description 2
- 241000888616 Hepacivirus A Species 0.000 claims description 2
- 241000888650 Hepacivirus K Species 0.000 claims description 2
- 235000005206 Hibiscus Nutrition 0.000 claims description 2
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 claims description 2
- 244000284380 Hibiscus rosa sinensis Species 0.000 claims description 2
- 208000017604 Hodgkin disease Diseases 0.000 claims description 2
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 2
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 2
- 241001503238 Homalodisca vitripennis Species 0.000 claims description 2
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 claims description 2
- 101000806663 Homo sapiens Aquaporin-4 Proteins 0.000 claims description 2
- 101000740062 Homo sapiens BAG family molecular chaperone regulator 1 Proteins 0.000 claims description 2
- 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 claims description 2
- 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 claims description 2
- 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 claims description 2
- 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 claims description 2
- 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 claims description 2
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 claims description 2
- 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 claims description 2
- 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 claims description 2
- 101000713078 Homo sapiens C-C motif chemokine 24 Proteins 0.000 claims description 2
- 101000897486 Homo sapiens C-C motif chemokine 25 Proteins 0.000 claims description 2
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims description 2
- 101000897494 Homo sapiens C-C motif chemokine 27 Proteins 0.000 claims description 2
- 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 claims description 2
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims description 2
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims description 2
- 101000946794 Homo sapiens C-C motif chemokine 8 Proteins 0.000 claims description 2
- 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 claims description 2
- 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 claims description 2
- 101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims description 2
- 101000858068 Homo sapiens C-X-C motif chemokine 14 Proteins 0.000 claims description 2
- 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 claims description 2
- 101000889048 Homo sapiens C-X-C motif chemokine 17 Proteins 0.000 claims description 2
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 claims description 2
- 101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 claims description 2
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims description 2
- 101100275820 Homo sapiens CSDE1 gene Proteins 0.000 claims description 2
- 101000804771 Homo sapiens Cytokine SCM-1 beta Proteins 0.000 claims description 2
- 101000804865 Homo sapiens E3 ubiquitin-protein ligase XIAP Proteins 0.000 claims description 2
- 101000899240 Homo sapiens Endoplasmic reticulum chaperone BiP Proteins 0.000 claims description 2
- 101000978392 Homo sapiens Eotaxin Proteins 0.000 claims description 2
- 101100281008 Homo sapiens FGF2 gene Proteins 0.000 claims description 2
- 101000854520 Homo sapiens Fractalkine Proteins 0.000 claims description 2
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims description 2
- 101001016865 Homo sapiens Heat shock protein HSP 90-alpha Proteins 0.000 claims description 2
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 claims description 2
- 101000972291 Homo sapiens Lymphoid enhancer-binding factor 1 Proteins 0.000 claims description 2
- 101000804764 Homo sapiens Lymphotactin Proteins 0.000 claims description 2
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 claims description 2
- 101100519221 Homo sapiens PDGFB gene Proteins 0.000 claims description 2
- 101000947178 Homo sapiens Platelet basic protein Proteins 0.000 claims description 2
- 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 claims description 2
- 101000864780 Homo sapiens Pulmonary surfactant-associated protein A1 Proteins 0.000 claims description 2
- 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 claims description 2
- 101000775102 Homo sapiens Transcriptional coactivator YAP1 Proteins 0.000 claims description 2
- 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 claims description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims description 2
- 241000709694 Human parechovirus 1 Species 0.000 claims description 2
- 241000172466 Human parechovirus 5 Species 0.000 claims description 2
- 241000315992 Human pegivirus 2 Species 0.000 claims description 2
- 241000709701 Human poliovirus 1 Species 0.000 claims description 2
- 241000710124 Human rhinovirus A2 Species 0.000 claims description 2
- 241000178632 Human rhinovirus A21 Species 0.000 claims description 2
- 101100273566 Humulus lupulus CCL10 gene Proteins 0.000 claims description 2
- 206010021042 Hypopharyngeal cancer Diseases 0.000 claims description 2
- 206010056305 Hypopharyngeal neoplasm Diseases 0.000 claims description 2
- 108091008036 Immune checkpoint proteins Proteins 0.000 claims description 2
- 102000037982 Immune checkpoint proteins Human genes 0.000 claims description 2
- 108090000171 Interleukin-18 Proteins 0.000 claims description 2
- 102100026236 Interleukin-8 Human genes 0.000 claims description 2
- 241000701646 Kappapapillomavirus 2 Species 0.000 claims description 2
- 241000960414 Kashmir bee virus Species 0.000 claims description 2
- 206010023825 Laryngeal cancer Diseases 0.000 claims description 2
- 206010024291 Leukaemias acute myeloid Diseases 0.000 claims description 2
- 102000003960 Ligases Human genes 0.000 claims description 2
- 108090000364 Ligases Proteins 0.000 claims description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 2
- 206010025323 Lymphomas Diseases 0.000 claims description 2
- 102100035304 Lymphotactin Human genes 0.000 claims description 2
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 claims description 2
- 208000000172 Medulloblastoma Diseases 0.000 claims description 2
- 206010027406 Mesothelioma Diseases 0.000 claims description 2
- 101001046872 Mus musculus Hypoxia-inducible factor 1-alpha Proteins 0.000 claims description 2
- 101100140104 Mus musculus Rbm3 gene Proteins 0.000 claims description 2
- 206010028729 Nasal cavity cancer Diseases 0.000 claims description 2
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 claims description 2
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 2
- 208000010505 Nose Neoplasms Diseases 0.000 claims description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- 206010033128 Ovarian cancer Diseases 0.000 claims description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 2
- 206010033799 Paralysis Diseases 0.000 claims description 2
- 241000406120 Pasivirus Species 0.000 claims description 2
- 241000682990 Pegivirus A Species 0.000 claims description 2
- 208000009565 Pharyngeal Neoplasms Diseases 0.000 claims description 2
- 206010034811 Pharyngeal cancer Diseases 0.000 claims description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 2
- 241001492235 Picobirnavirus Species 0.000 claims description 2
- 102100036154 Platelet basic protein Human genes 0.000 claims description 2
- 102100030304 Platelet factor 4 Human genes 0.000 claims description 2
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 claims description 2
- 241001527104 Plautia stali Species 0.000 claims description 2
- 108010020346 Polyglutamic Acid Chemical class 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 238000010357 RNA editing Methods 0.000 claims description 2
- 230000026279 RNA modification Effects 0.000 claims description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 2
- 241000712909 Reticuloendotheliosis virus Species 0.000 claims description 2
- 241000551466 Rosavirus B Species 0.000 claims description 2
- 241001516344 Rosavirus M-7 Species 0.000 claims description 2
- 241000033084 Salivirus A Species 0.000 claims description 2
- 241001574489 Salivirus FHB Species 0.000 claims description 2
- 241000180008 Salivirus NG-J1 Species 0.000 claims description 2
- 241001333897 Sapelovirus Species 0.000 claims description 2
- 206010039710 Scleroderma Diseases 0.000 claims description 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
- 208000032383 Soft tissue cancer Diseases 0.000 claims description 2
- 241000517830 Solenopsis geminata Species 0.000 claims description 2
- 241000736128 Solenopsis invicta Species 0.000 claims description 2
- 208000000102 Squamous Cell Carcinoma of Head and Neck Diseases 0.000 claims description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 2
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims description 2
- 208000018359 Systemic autoimmune disease Diseases 0.000 claims description 2
- 102100040296 TATA-box-binding protein Human genes 0.000 claims description 2
- 241001265687 Taura syndrome virus Species 0.000 claims description 2
- 208000024313 Testicular Neoplasms Diseases 0.000 claims description 2
- 206010057644 Testis cancer Diseases 0.000 claims description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 2
- 241000723792 Tobacco etch virus Species 0.000 claims description 2
- 241000723848 Tobamovirus Species 0.000 claims description 2
- 108010083268 Transcription Factor TFIID Proteins 0.000 claims description 2
- 102100031873 Transcriptional coactivator YAP1 Human genes 0.000 claims description 2
- 241001480150 Triatoma virus Species 0.000 claims description 2
- 102100034131 Tumor necrosis factor alpha-induced protein 8-like protein 2 Human genes 0.000 claims description 2
- 101710177302 Tumor necrosis factor alpha-induced protein 8-like protein 2 Proteins 0.000 claims description 2
- 241000714211 Turnip crinkle virus Species 0.000 claims description 2
- 208000023915 Ureteral Neoplasms Diseases 0.000 claims description 2
- 206010046392 Ureteric cancer Diseases 0.000 claims description 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 2
- 208000004354 Vulvar Neoplasms Diseases 0.000 claims description 2
- 101001001642 Xenopus laevis Serine/threonine-protein kinase pim-3 Proteins 0.000 claims description 2
- 230000001154 acute effect Effects 0.000 claims description 2
- 239000000556 agonist Substances 0.000 claims description 2
- 206010065867 alveolar rhabdomyosarcoma Diseases 0.000 claims description 2
- 210000002255 anal canal Anatomy 0.000 claims description 2
- 201000007696 anal canal cancer Diseases 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 210000003719 b-lymphocyte Anatomy 0.000 claims description 2
- 229920002988 biodegradable polymer Polymers 0.000 claims description 2
- 239000004621 biodegradable polymer Substances 0.000 claims description 2
- 201000001531 bladder carcinoma Diseases 0.000 claims description 2
- 244000144987 brood Species 0.000 claims description 2
- 108091008816 c-sis Proteins 0.000 claims description 2
- 201000010881 cervical cancer Diseases 0.000 claims description 2
- 235000012000 cholesterol Nutrition 0.000 claims description 2
- 230000001684 chronic effect Effects 0.000 claims description 2
- 101150096566 clpX gene Proteins 0.000 claims description 2
- 206010009887 colitis Diseases 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 230000000139 costimulatory effect Effects 0.000 claims description 2
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 210000000959 ear middle Anatomy 0.000 claims description 2
- 201000002491 encephalomyelitis Diseases 0.000 claims description 2
- 201000004101 esophageal cancer Diseases 0.000 claims description 2
- 208000024519 eye neoplasm Diseases 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- 206010017758 gastric cancer Diseases 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 201000009277 hairy cell leukemia Diseases 0.000 claims description 2
- 201000010536 head and neck cancer Diseases 0.000 claims description 2
- 201000000459 head and neck squamous cell carcinoma Diseases 0.000 claims description 2
- 102000057121 human AQP4 Human genes 0.000 claims description 2
- 102000051711 human BCL2 Human genes 0.000 claims description 2
- 102000046317 human CSDE1 Human genes 0.000 claims description 2
- 102000048874 human LEF1 Human genes 0.000 claims description 2
- 102000053563 human MYC Human genes 0.000 claims description 2
- 102000054741 human SFTPA1 Human genes 0.000 claims description 2
- 102000058223 human VEGFA Human genes 0.000 claims description 2
- 102000052732 human XIAP Human genes 0.000 claims description 2
- 208000006278 hypochromic anemia Diseases 0.000 claims description 2
- 201000006866 hypopharynx cancer Diseases 0.000 claims description 2
- 229940126546 immune checkpoint molecule Drugs 0.000 claims description 2
- 230000001506 immunosuppresive effect Effects 0.000 claims description 2
- 108091006086 inhibitor proteins Proteins 0.000 claims description 2
- 210000003228 intrahepatic bile duct Anatomy 0.000 claims description 2
- 238000002955 isolation Methods 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 206010023841 laryngeal neoplasm Diseases 0.000 claims description 2
- 208000032839 leukemia Diseases 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 201000007270 liver cancer Diseases 0.000 claims description 2
- 208000014018 liver neoplasm Diseases 0.000 claims description 2
- 201000005249 lung adenocarcinoma Diseases 0.000 claims description 2
- 201000005202 lung cancer Diseases 0.000 claims description 2
- 208000020816 lung neoplasm Diseases 0.000 claims description 2
- 206010025135 lupus erythematosus Diseases 0.000 claims description 2
- 230000036210 malignancy Effects 0.000 claims description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 2
- 208000026037 malignant tumor of neck Diseases 0.000 claims description 2
- 201000006512 mast cell neoplasm Diseases 0.000 claims description 2
- 201000001441 melanoma Diseases 0.000 claims description 2
- 201000003956 middle ear cancer Diseases 0.000 claims description 2
- 108700040054 mouse Nkx6-2 Proteins 0.000 claims description 2
- 201000006417 multiple sclerosis Diseases 0.000 claims description 2
- 206010028417 myasthenia gravis Diseases 0.000 claims description 2
- 210000003928 nasal cavity Anatomy 0.000 claims description 2
- 201000007425 nasal cavity carcinoma Diseases 0.000 claims description 2
- 201000011216 nasopharynx carcinoma Diseases 0.000 claims description 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 2
- 201000008106 ocular cancer Diseases 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 210000002747 omentum Anatomy 0.000 claims description 2
- 201000002528 pancreatic cancer Diseases 0.000 claims description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 2
- 201000002628 peritoneum cancer Diseases 0.000 claims description 2
- 201000003437 pleural cancer Diseases 0.000 claims description 2
- 229920002643 polyglutamic acid Chemical class 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 208000005987 polymyositis Diseases 0.000 claims description 2
- 206010038038 rectal cancer Diseases 0.000 claims description 2
- 201000001275 rectum cancer Diseases 0.000 claims description 2
- 206010039083 rhinitis Diseases 0.000 claims description 2
- 230000019491 signal transduction Effects 0.000 claims description 2
- 201000000849 skin cancer Diseases 0.000 claims description 2
- 201000002314 small intestine cancer Diseases 0.000 claims description 2
- 201000011549 stomach cancer Diseases 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 206010042863 synovial sarcoma Diseases 0.000 claims description 2
- 201000003120 testicular cancer Diseases 0.000 claims description 2
- 201000002510 thyroid cancer Diseases 0.000 claims description 2
- 206010043778 thyroiditis Diseases 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims description 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 2
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 2
- 208000010570 urinary bladder carcinoma Diseases 0.000 claims description 2
- 101710116034 Immunity protein Proteins 0.000 claims 2
- YZXBAPSDXZZRGB-NYMQMLLSSA-N (5e,8z,11z,14z)-icosa-5,8,11,14-tetraenoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C\CCCC(O)=O YZXBAPSDXZZRGB-NYMQMLLSSA-N 0.000 claims 1
- 101710181148 50S ribosomal protein L9, chloroplastic Proteins 0.000 claims 1
- 108010055288 Chemokine CCL1 Proteins 0.000 claims 1
- 102000000021 Chemokine CCL1 Human genes 0.000 claims 1
- 108020004705 Codon Proteins 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 101100222387 Mus musculus Cxcl15 gene Proteins 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 150000001923 cyclic compounds Chemical class 0.000 claims 1
- 201000010175 gallbladder cancer Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 description 11
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 102100023700 C-C motif chemokine 16 Human genes 0.000 description 1
- 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
- 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 1
- 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 201000007487 gallbladder carcinoma Diseases 0.000 description 1
- 230000003259 immunoinhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000000581 natural killer T-cell Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062992518P | 2020-03-20 | 2020-03-20 | |
| US62/992,518 | 2020-03-20 | ||
| PCT/US2021/023540 WO2021189059A2 (en) | 2020-03-20 | 2021-03-22 | Circular rna compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518295A JP2023518295A (ja) | 2023-04-28 |
| JPWO2021189059A5 true JPWO2021189059A5 (ru) | 2024-02-15 |
Family
ID=75539941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022556568A Pending JP2023518295A (ja) | 2020-03-20 | 2021-03-22 | 環状ｒｎａ組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4121453A2 (ru) |
| JP (1) | JP2023518295A (ru) |
| KR (1) | KR20230069042A (ru) |
| CN (1) | CN116034114A (ru) |
| AU (1) | AU2021237738A1 (ru) |
| BR (1) | BR112022018854A2 (ru) |
| CA (1) | CA3172423A1 (ru) |
| MX (1) | MX2022011677A (ru) |
| WO (1) | WO2021189059A2 (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3801639A1 (en) | 2018-06-06 | 2021-04-14 | Massachusetts Institute of Technology | Circular rna for translation in eukaryotic cells |
| KR102442946B1 (ko) | 2021-03-10 | 2022-09-15 | 알지노믹스 주식회사 | 자가 환형화 rna 구조체 |
| CN113999852B (zh) * | 2021-11-30 | 2024-04-02 | 杭州市富阳区第一人民医院 | circ_0001772作为结直肠癌诊断和治疗标志物的应用 |
| WO2023107593A2 (en) * | 2021-12-09 | 2023-06-15 | Carisma Therapeutics Inc. | In vivo delivery to immune cells |
| CN114574483B (zh) * | 2022-03-02 | 2024-05-10 | 苏州科锐迈德生物医药科技有限公司 | 基于翻译起始元件点突变的重组核酸分子及其在制备环状rna中的应用 |
| CN114438127B (zh) * | 2022-03-02 | 2024-03-19 | 苏州科锐迈德生物医药科技有限公司 | 一种重组核酸分子及其在制备环状rna中的应用 |
| WO2023182948A1 (en) * | 2022-03-21 | 2023-09-28 | Bio Adventure Co., Ltd. | Internal ribosome entry site (ires), plasmid vector and circular mrna for enhancing protein expression |
| WO2024008189A1 (en) * | 2022-07-08 | 2024-01-11 | Shanghai Circode Biomed Co., Ltd. | Methods and systems for purifying circular nucleic acids |
| WO2024030957A1 (en) * | 2022-08-02 | 2024-02-08 | William Marsh Rice University | Compositions and methods for facilitating heart and lung repair |
| WO2024092001A1 (en) * | 2022-10-26 | 2024-05-02 | Memorial Sloan-Kettering Cancer Center | Cd33 antibody compositions for treating alzheimer's disease |
| WO2024102677A1 (en) | 2022-11-08 | 2024-05-16 | Orna Therapeutics, Inc. | Circular rna compositions |
| WO2024112717A1 (en) * | 2022-11-21 | 2024-05-30 | Avstera Therapeutics Corp. | Mrna composition for preventing and treating cancer |
| CN116284006B (zh) * | 2023-05-10 | 2023-08-25 | 北京因诺惟康医药科技有限公司 | 可电离脂质化合物、包含其的脂质载体及应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319494B1 (en) | 1990-12-14 | 2001-11-20 | Cell Genesys, Inc. | Chimeric chains for receptor-associated signal transduction pathways |
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| IL135578A0 (en) | 1997-10-29 | 2001-05-20 | Genzyme Corp | Compositions and methods for treating lysosomal storage disease |
| US5948902A (en) | 1997-11-20 | 1999-09-07 | South Alabama Medical Science Foundation | Antisense oligonucleotides to human serine/threonine protein phosphatase genes |
| WO2001060414A2 (en) | 2000-02-17 | 2001-08-23 | Genzyme Corporation | Genetic modification of the lung as a portal for gene delivery |
| EP2298809A3 (en) | 2001-07-12 | 2012-02-15 | FOOTE, Jefferson | Super humanized antibodies |
| US20040014194A1 (en) | 2002-03-27 | 2004-01-22 | Schering Corporation | Beta-secretase crystals and methods for preparing and using the same |
| ES2367430T3 (es) | 2002-12-23 | 2011-11-03 | Wyeth Llc | Anticuerpos contra pd-1 y sus usos. |
| ATE475669T1 (de) | 2004-06-29 | 2010-08-15 | Immunocore Ltd | Einen modifizierten t-zellen-rezeptor exprimierende zellen |
| ES2427646T5 (es) | 2005-05-09 | 2017-08-22 | Ono Pharmaceutical Co., Ltd. | Anticuerpos monoclonales humanos contra muerte programada 1 (PD1) y métodos para el tratamiento del cáncer mediante el uso de anticuerpos anti-PD-1 solos o combinados con otros agentes inmunoterapéuticos |
| PT2242773T (pt) | 2008-02-11 | 2017-09-15 | Cure Tech Ltd | Anticorpos monoclonais para o tratamento de tumores |
| EP2262837A4 (en) | 2008-03-12 | 2011-04-06 | Merck Sharp & Dohme | PD-1 BINDING PROTEINS |
| EP2328919A2 (en) | 2008-08-25 | 2011-06-08 | Amplimmune, Inc. | Pd-i antagonists and methods for treating infectious disease |
| WO2010027423A2 (en) | 2008-08-25 | 2010-03-11 | Amplimmune, Inc. | Compositions of pd-1 antagonists and methods of use |
| US20130017199A1 (en) | 2009-11-24 | 2013-01-17 | AMPLIMMUNE ,Inc. a corporation | Simultaneous inhibition of pd-l1/pd-l2 |
| ES2774968T3 (es) | 2013-12-19 | 2020-07-23 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| LT3350157T (lt) | 2015-09-17 | 2022-02-25 | Modernatx, Inc. | Junginiai ir kompozicijos terapinei medžiagai teikti intraceliuliniu būdu |
| CA3201644A1 (en) | 2015-10-28 | 2017-05-04 | Acuitas Therapeutics, Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| US20200306286A1 (en) * | 2017-12-15 | 2020-10-01 | Flagship Pioneering Innovations Vi, Llc | Compositions comprising circular polyribonucleotides and uses thereof |
| EP3746052A1 (en) * | 2018-01-30 | 2020-12-09 | Modernatx, Inc. | Compositions and methods for delivery of agents to immune cells |
| WO2019152848A1 (en) | 2018-02-01 | 2019-08-08 | Trustees Of Tufts College | Lipid-like nanocomplexes and uses thereof |
| US20230149310A1 (en) | 2018-03-30 | 2023-05-18 | Arcturus Therapeutics, Inc. | Lipid particles for nucleic acid delivery |
| WO2019213308A1 (en) * | 2018-05-01 | 2019-11-07 | Fred Hutchinson Cancer Research Center | Nanoparticles for gene expression and uses thereof |
| WO2019222275A2 (en) * | 2018-05-14 | 2019-11-21 | TCR2 Therapeutics Inc. | Compositions and methods for tcr reprogramming using inducible fusion proteins |
| EP3826643A4 (en) * | 2018-07-24 | 2022-05-18 | Mayo Foundation for Medical Education and Research | CIRCULARIZED MANIPULATED RNA AND METHODS |
| KR20220027855A (ko) * | 2019-05-22 | 2022-03-08 | 매사추세츠 인스티튜트 오브 테크놀로지 | 원형 rna 조성물 및 방법 |
-
2021
- 2021-03-22 JP JP2022556568A patent/JP2023518295A/ja active Pending
- 2021-03-22 AU AU2021237738A patent/AU2021237738A1/en active Pending
- 2021-03-22 BR BR112022018854A patent/BR112022018854A2/pt unknown
- 2021-03-22 WO PCT/US2021/023540 patent/WO2021189059A2/en active Application Filing
- 2021-03-22 CN CN202180036474.XA patent/CN116034114A/zh active Pending
- 2021-03-22 CA CA3172423A patent/CA3172423A1/en active Pending
- 2021-03-22 KR KR1020227036619A patent/KR20230069042A/ko active Search and Examination
- 2021-03-22 EP EP21719357.2A patent/EP4121453A2/en active Pending
- 2021-03-22 MX MX2022011677A patent/MX2022011677A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lu et al. | Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes | |
| JP7264329B2 (ja) | Ｔ細胞療法を向上させるための、哺乳動物ｔ細胞の活性化により誘導可能な合成プロモーター（ｓｙｎ＋ｐｒｏ）の作製 | |
| JP6416628B2 (ja) | 標的変異体αヘリックスバンドルサイトカイン | |
| JPWO2021189059A5 (ru) | ||
| Pollard et al. | Interferon-γ and systemic autoimmunity | |
| RU2015148920A (ru) | Расширенная адоптивная клеточная терапия | |
| Morrow et al. | A novel role for IFN-stimulated gene factor 3II in IFN-γ signaling and induction of antiviral activity in human cells | |
| US20240150428A1 (en) | Genome-edited invariant natural killer t (inkt) cells for the treatment of hematologic malignancies | |
| JPWO2020237227A5 (ru) | ||
| Grine et al. | Dual inhibition of TNFR1 and IFNAR1 in imiquimod-induced psoriasiform skin inflammation in mice | |
| JP2018514199A5 (ru) | ||
| US20220125951A1 (en) | Microenvironment sensors to regulate engineered gene expression | |
| US11896635B2 (en) | Oncolytic virus (oncolytic immunotherapy) capable of effectively treating even metastatic cancer while ensuring safety, with expression control system providing optimal expression level of mounted immunogenic gene | |
| Wu et al. | Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3 | |
| Bordon et al. | The atypical chemokine receptor D6 contributes to the development of experimental colitis | |
| Takeuchi et al. | Phase II/III results of a trial of anti–tumor necrosis factor multivalent NANOBODY compound ozoralizumab in patients with rheumatoid arthritis | |
| Yoshinaga et al. | Post‐transcriptional control of immune responses and its potential application | |
| US20160102127A1 (en) | Targeted modulation of macrophages | |
| Kottke et al. | Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy | |
| WO2021032116A1 (zh) | 一种免疫细胞因子及其制备与用途 | |
| Nagayama et al. | Overexpression of Interferonγ-Inducible Protein 10 in The Liver of Patients With Type I Autoimmune Hepatitis Identified by Suppression Subtractive Hybridization | |
| Kirou et al. | Activation of type I interferon in systemic lupus erythematosus | |
| Büssow et al. | ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells | |
| Calugareanu et al. | Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus. | |
| Bank | A Cohort of Anti-TNF Treated Danish Patients with Inflammatory Bowel Disease, Used for Identifying Genetic Markers Associated with Treatment Response: PhD Dissertation |